Latest news with #Gastroenterology
SBS Australia
24-05-2025
- Health
- SBS Australia
Suffering in silence: the rapidly rising disease impacting Australians
In her first year of university, when Natasha Jiwani should have been revelling in her new-found independence, she started to experience constant abdominal pain. "I straight after finishing high school, first year of university would get severe abdominal pain to the point where I would wake up with it and go to sleep with it. No one could diagnose what it was." Eventually, Natasha was diagnosed with Crohn's disease. "The overall experience was quite different. So, walking into a gastroenterologist waiting room, I'd look around and I was the only one that was in my close to 20's. Everybody else, the average age was 60 onwards, so there was a lot of confusion." Crohn's disease and ulcerative colitis both fall under the umbrella term of Inflammatory Bowel Disease, or IBD — an autoimmune disease where the body's immune system attacks the gut. Crohn's disease can cause inflammation anywhere in the digestive system, though it usually affects the bowels. Ulcerative colitis, often referred to simply as "colitis", can cause inflammation and ulcers in the colon and rectum. Vincent Ho, a gastroenterologist at Western Sydney University, says both conditions cause multiple symptoms including diarrhea and abdominal pain, though to others they remain invisible. "People with inflammatory bowel disease may look perfectly fine but are actually suffering from the symptoms of inflammatory bowel disease, which can be quite severe in many cases and affect their daily life." The number of Australians living with I-B-D is rapidly on the rise, increasing from 100,000 a decade or so ago to around 180,000 today, according to a recent State of the Nation Report. That number is expected to rise to 200,000 in the next 10 years. Doctor Ho says the rates of IBD in Australia are among the highest in the world. "Over 65, we're seeing more cases, but we're also seeing cases of inflammatory bowel disease in young children as well. And there are a number of cases of what we call very early onset in inflammatory bowel disease where children can get it a younger than six years of age." Dr Ho say, while it's largely unknown how this inflammation arises, we are starting to learn more about its causes. "Some risk factors in the environment include exposure to tobacco smoke, the use of antibiotics, the use of certain drugs like non-steroidal anti-inflammatory drugs, for example Nurofen, Voltaren, those sorts of drugs. We know that some types of infections can increase the risk of developing inflammatory bowel disease." Another risk factor is diet. One recent world-first pre clinical study, by the Walter and Eliza Hall Institute of Medical Research, shows how eating just a few meals high in saturated fats, can cause inflammation in the body. Those foods can also weaken the production of a crucial protein called IL-22, which helps fight this inflammation. Mice were used in this research, which also reveals something that excited researchers: while saturated fats suppress IL-22 production, unsaturated fats, found in nuts and avocados, actually boost the protein's production. Dr Ho says this provides immense hope for people living with chronic inflammatory diseases like IBD. "We know that certain types of foods, a high-quality diet, for example, reaching fruit, vegetables, fish, and other fibre sources is considered to be a protective factor when it comes to inflammatory bowel disease." Natasha has found eating well has had a huge impact on her symptoms. "I know that if I'm living off fast food for a week as opposed to making healthy at home meals, my Crohn's is a lot better in that latter thing because my body's healthier and it's ensuring that my body's not flaring up with what I'm eating." While IBD is a chronic condition with no cure, it can be managed with treatment. Early diagnosis is important, with symptoms including abnormal bowel movements and the presence of mucus or blood in stools, as well as abdominal discomfort, bloating and flatulence. Leanne Raven, CEO of Crohns and Colitis Australia, says greater awareness around I-B-D will also help when it comes to diagnosis, support and treatment. "Because it's below the belly button, people don't necessarily talk about it. So, a lot of people become quite isolated in trying to manage their conditions. So, we're trying to shatter the IBD silence through raising awareness of and encouraging people to have conversations." Natasha says while there is less stigma and embarrassment around I-B-D than ever before, more people need to talk about it. "I think what's really also important is clarifying the support that's available. I definitely do think awareness, raising funds, raising funds to help with finding a cure potentially for this disease as well would be amazing."
Yahoo
23-05-2025
- Health
- Yahoo
Gastroenterology Industry Analysis, Competitive Intelligence and Strategic Business Report 2025 with Insights on 41 Market Players
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Gastroenterology - Global Strategic Business Report" has been added to global market for Gastroenterology was valued at US$34.1 Billion in 2024 and is projected to reach US$45.7 Billion by 2030, growing at a CAGR of 5.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Gastroenterology market. The growth of the gastroenterology market is driven by several factors that combine advancements in technology, increasing disease prevalence, and a focus on patient-centered care. A key driver is the rising global prevalence of gastrointestinal diseases, particularly conditions like IBD, colorectal cancer, and NAFLD, which are more common due to modern lifestyle factors such as poor diets, smoking, and sedentary lifestyles. As these diseases become more prevalent, there is a greater demand for gastroenterology specialists, diagnostics, and treatments to manage these conditions. Additionally, technological innovations in diagnostics and treatments, such as AI-assisted endoscopy and minimally invasive surgeries, are improving the accuracy, speed, and patient outcomes associated with gastroenterology procedures. The integration of genomics into gastroenterology is also driving growth, as the field moves toward personalized medicine and targeted therapies for gastrointestinal diseases. The increasing focus on preventive care is another significant growth driver. With improved access to screenings for colorectal cancer, hepatitis, and other gastrointestinal diseases, healthcare systems can catch these conditions at earlier stages, leading to more effective treatment and improved survival rates. Moreover, the expanding middle class in emerging markets is contributing to the global growth of gastroenterology services, as more people seek specialized care for digestive disorders. Public health campaigns, government initiatives, and international efforts to raise awareness of gastrointestinal diseases are further fueling the demand for gastroenterology services. Finally, the growing interest in gut microbiota and its role in gastrointestinal health and overall well-being is sparking new research and treatment options, positioning gastroenterology at the forefront of medical innovation. Together, these factors are driving the expansion of the gastroenterology market and enhancing the quality of care for patients with digestive diseases ScopeThe report analyzes the Gastroenterology market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined Drug Type (Biologics / Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Other Drug Types); Disease Type (Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Irritable Bowel Syndrome, Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Other Disease Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Insights: Market Growth: Understand the significant growth trajectory of the Biologics / Biosimilars segment, which is expected to reach US$11.3 Billion by 2030 with a CAGR of a 3.8%. The Antacids segment is also set to grow at 4.8% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $9.3 Billion in 2024, and China, forecasted to grow at an impressive 7.7% CAGR to reach $8.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Key Questions Answered: How is the Global Gastroenterology Market expected to evolve by 2030? What are the main drivers and restraints affecting the market? Which market segments will grow the most over the forecast period? How will market shares for different regions and segments change by 2030? Who are the leading players in the market, and what are their prospects? Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as AbbVie Inc., Abbott Laboratories, AstraZeneca plc, Bayer AG, Bausch Health Companies Inc. and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Some of the 41 companies featured in this Gastroenterology market report include: AbbVie Inc. Abbott Laboratories AstraZeneca plc Bayer AG Bausch Health Companies Inc. Boehringer Ingelheim GmbH Boston Scientific Corporation Cipla Ltd. Ferring Pharmaceuticals GI Alliance GlaxoSmithKline plc Johnson & Johnson Medtronic plc Novartis AG Olympus Corporation Pfizer Inc. Salix Pharmaceuticals Sanofi S.A. Sebela Pharmaceuticals Takeda Pharmaceutical Company Tariff Impact Analysis: Key Insights for 2025Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes Report Attribute Details No. of Pages 401 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $34.1 Billion Forecasted Market Value (USD) by 2030 $45.7 Billion Compound Annual Growth Rate 5% Regions Covered Global MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of COVID-19 and a Looming Global Recession Gastroenterology - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Increasing Prevalence of Gastrointestinal Disorders Drives Demand for Gastroenterology Services and Treatments Here's the Story: How Advancements in Endoscopic Technology Are Revolutionizing Gastroenterology Diagnostics Rising Awareness of Digestive Health and Wellness Fuels Growth in Preventive and Diagnostic Gastroenterology Services Technological Innovations in Minimally Invasive Procedures Expand Treatment Options for Gastrointestinal Disorders Surge in Aging Populations Globally Increases the Need for Gastroenterology Care and Disease Management Here's How the Growing Focus on Personalized Medicine is Shaping the Future of Gastroenterology Treatments Rising Incidence of Inflammatory Bowel Diseases (IBD) and Celiac Disease Strengthens the Business Case for Specialized Care Expanding Role of Telemedicine and Remote Monitoring Drives Access to Gastroenterology Services in Underserved Areas Increasing Research and Clinical Trials in Microbiome and Gut Health Create New Opportunities for Therapeutic Advancements Here's How Advances in Artificial Intelligence and Machine Learning are Revolutionizing Gastroenterology Diagnostics Growing Demand for Targeted Therapies and Biologics in Treating Gastrointestinal Disorders Expands Treatment Options Global Increase in Obesity and Lifestyle-Related Disorders Drives Growth in Gastroenterology-Based Disease Prevention For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Washington Post
17-02-2025
- Health
- Washington Post
Study: Nearly 7 in 10 U.S. counties have no gastroenterologists
About 69 percent of U.S. counties have no gastroenterologist, leaving people in many rural areas without a nearby digestive specialist, according to a research letter published in the journal Gastroenterology. Researchers at Weill Cornell Medicine found that over two-thirds of the 3,149 counties in the United States had no gastroenterologist, leaving about 49 million Americans — mostly in rural areas — to drive 25 miles or more for such specialty care within their county. The researchers drew from data on U.S. physician workforce distribution and the 2020 U.S. Census.
Yahoo
14-02-2025
- Health
- Yahoo
NC physician: New study confirms importance of diet to protect against gastrointestinal cancers
Photo: National Institutes of Health A new study published in the medical journal Gastroenterology shows the number of gastrointestinal cancer cases, including colorectal cancer, related to poor diet doubled globally between 1990 and 2018. The leading dietary risk factors, the researchers from Wuhan, China reported, were the consumption of too much processed meat and not enough fruit and whole grains. As an internal medicine specialist and pediatrician practicing in Huntersville, I'm not surprised by the findings. I routinely recommend screening colonoscopies to my patients over 45, a recommendation that used to be age 50. I can't believe how many of these young adults are found to have adenomatous polyps, many of which would have been destined to become colon cancer. While overall rates of colorectal cancer are down in the United States, I've seen an increase in recent years in younger patients being diagnosed. Research confirms this is a nationwide trend. Adults born around 1990 have twice the risk of colon cancer and four times the risk of rectal cancer compared with those born around 1950, a study published by the National Cancer Institute says. And colorectal cancer has become the deadliest cancer in men ages 20 to 49. If there's any silver lining in all of this dismal news, it's that the risk factors for gastrointestinal cancers ARE modifiable. And the new study from China offers a bit of hope. Many of these cancers, it suggests, are largely preventable. In my practice, I advocate for fiber-rich whole food, plant-based diets for my patients. Research supports the benefits of a plant-based diet for reducing the risks of a number of diseases, including heart attacks, diabetes, and stroke. A plant-based diet is also a powerful tool for weight loss. That's important since data shows that in 23 states, more than 1 in 3 adults is obese. And across the country, 3 out of 4 adults are obese or overweight. As for the gastrointestinal system, a plant-based diet provides strong colon cancer prevention. For example, this study, published online in BMC Medicine, showed men who ate the most plant-based foods had a 22% reduced risk of colon cancer, compared with those who ate the least. High in fiber, plant foods are quickly whisked through the colon. This reduces the contact between carcinogens and the digestive tract. Plant foods also are high in phytonutrients and antioxidants, which are known anti-cancer agents. A diet high in red meat, studies have found, increases the risk for colorectal cancer. For example, one study, published in the Journal of Nutrition and based on food questionnaires from more than 50,000 Black, female participants, showed a 33% increased risk for late-onset colorectal cancer for every 100 grams (3.5 ounces) of red meat eaten per day. For those new to plant-based eating, the Physicians Committee for Responsible Medicine has some tips for getting started. The health advocacy organization recommends keeping it simple when it comes to transitioning to a vegan diet. Focus on minimally processed plant foods, avoid animal products, limit saturated fats, and minimize the use of cooking oils. Stock up on fruits, vegetables, whole grains, legumes and lentils and plan meals around these ingredients. North Carolina Gov. Josh Stein has proclaimed March Colorectal Cancer Awareness Month. I encourage all North Carolinians to take note. Talk to your doctor about changes in bowel habits. When you turn 45, follow American Cancer Society guidance and begin screenings. And modify the preventable risk factors the Wuhan, China, researchers identified. Stop eating processed meat like ham, bacon, and hot dogs. Instead, bulk up on whole grains, like brown rice, quinoa, and oats, and start eating a wide range of nutrient- and fiber-rich fresh fruit and vegetables. It will give your body the protection it needs from colorectal cancer and a host of other potentially fatal diseases.
